TELDY (Tenofovir,Lamivudine,Dolutegravir)
Teldy (TLD) is a single-pill antiretroviral therapy combining dolutegravir, lamivudine, and tenofovir disoproxil fumarate for treating HIV.
- The description claims TLD works by reducing HIV viral load.
- The description claims TLD is indicated for adults and adolescents weighing at least 40 kg.
- The description claims side effects may include difficulty sleeping or mood changes.
- The description claims TLD is a cost-effective generic medication widely available in low and middle-income countries.
Specifications
- Form & Size
- TELDY 50mg/300mg/300mg bottle of 30's
Variants (1)
- TELDY 50mg/300mg/300mg bottle of 30's — 3591.00 PHP — In stock
AI Readiness
Good foundation, but some important product data is still missing.
76%